123 results
8-K
PRAX
Praxis Precision Medicines Inc
13 May 24
Praxis Precision Medicines Provides Corporate Update and Reports First Quarter 2024 Financial Results
8:18am
information is unaudited and is subject to completion of the Company’s financial closing procedures. The Company’s independent registered public accounting
8-K
EX-1.1
PRAX
Praxis Precision Medicines Inc
29 Mar 24
Other Events
4:30pm
or contemplated in the Registration Statement, the Time of Sale Prospectus and the Prospectus.
(i) Independent Accountants. Ernst & Young LLP, who has certified … Statement, the Time of Sale Prospectus and the Prospectus is an independent registered public accounting firm with respect to the Company and its
424B5
PRAX
Praxis Precision Medicines Inc
29 Mar 24
Prospectus supplement for primary offering
4:29pm
display its bid at a price not in excess of the highest independent bid of that security. However, if all independent bids are lowered below … ) for the year ended December 31, 2023, have been audited by Ernst & Young LLP, independent registered public accounting firm, as set forth in their report
424B5
PRAX
Praxis Precision Medicines Inc
27 Mar 24
Prospectus supplement for primary offering
4:49pm
and extending through the completion of distribution. A passive market maker must display its bid at a price not in excess of the highest independent bid … of that security. However, if all independent bids are lowered below the passive market maker’s bid, that bid must then be lowered when specified purchase
S-3
EX-4.4
d7i fba6rut
5 Mar 24
Shelf registration
9:08am
S-3
EX-23.2
k10d1lme
5 Mar 24
Shelf registration
9:08am
S-3
ltg e2f4s3bf1doy0txh
5 Mar 24
Shelf registration
9:08am
S-3
EX-1.2
3lzxssubg0 s2s6fudb
5 Mar 24
Shelf registration
9:08am
S-8
EX-23.1
2jfm24q
5 Mar 24
Registration of securities for employees
7:33am
S-8
8x8pmkm2nry35s
5 Mar 24
Registration of securities for employees
7:33am
8-K
6ad 4q997vgz42jtn
5 Mar 24
Praxis Precision Medicines Provides Corporate Update and Reports Fourth Quarter and Full-Year 2023 Financial Results
7:13am
8-K
EX-99.2
wqchfe2 bsjqn
5 Mar 24
Praxis Precision Medicines Provides Corporate Update and Reports Fourth Quarter and Full-Year 2023 Financial Results
7:13am
S-8
EX-99.1
oxg5j
31 Jan 24
Registration of securities for employees
4:20pm
S-8
EX-23.1
xayhg102mnzmzakt5hbi
31 Jan 24
Registration of securities for employees
4:20pm
S-8
kbkji7a
31 Jan 24
Registration of securities for employees
4:20pm